APOE and Alzheimer disease: Using the well-known apolipoprotein E genotype (APOE), we demonstrated that among a group of only about 500 community based elderly with European ancestry, quantitative pathologic AD phenotypes provide considerably more power than phenotypes of clinical AD diagnosis or cognitive function [79•].